Disease-Free Survival

Actionable Insights Powered by AI

AstraZeneca’s Imfinzi Achieves Success in Bladder Cancer Trial, Falls Short in Lung Cancer Study

AstraZeneca, Imfinzi, bladder cancer, lung cancer, Phase III trials, disease-free survival